Portfolio company
Serinus Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops an artificial intelligence platform to design cancer therapeutics and combination therapies for the pharmaceutical and precision medicine industries.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Meliora Therapeutics
This company develops a machine-learning platform to identify drug mechanisms and create precision oncology treatments for pharmaceutical partners and cancer patients.
Alceus
This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.
Auron Therapeutics
This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
CoSyne Therapeutics
The company develops artificial intelligence platforms to discover precision medicines for patients with brain cancer and neurological conditions.
Auransa
This biotechnology company develops precision medicines for cancer and other diseases using an artificial intelligence platform to identify novel therapies and patient subgroups.
Cartography Biosciences
This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.
Ataraxis AI
This company develops artificial intelligence models that predict cancer outcomes and treatment responses for healthcare providers and oncologists.
